U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,732 records

Showing results for "secondary".

  1. Nis 2009 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Core.PDF
    January 01, 2009 - 1.00 0.29 0.46 PAY1 : Primary expected payer (uniform) 7,794,273 16,489 1.00 6.00 2.21 1.20 PAY2 : Secondary … Distribution for DRG24 DRG24 Frequency Percent of Total 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 26,044 0.33% 464: SIGNS & SYMPTOMS W/O CC 8,109 0.10% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 274 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 3,207 0.04% 467 … 0.11% 40: Multiple myeloma 3,623 0.05% 41: Cancer; other and unspecified primary 1,480 0.02% 42: Secondary

  2. Neds 2007 Maskedstats Ip (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_IP.PDF
    January 01, 2007 - NEOPL W OTHER O.R.PROC 195 0.01 409: RADIOTHERAPY 25 0.00 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 13,021 0.41 464: SIGNS & SYMPTOMS W/O CC 4,261 0.13 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 13 0.00 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 179 0.01 467: OTHER … DIAGNOSIS W MCC <= 10 *.** 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 110 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 13 0.00 849: RADIOTHERAPY <

  3. Neds 2018 Ip Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2018_IP_MaskedStats.PDF
    January 01, 2018 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 250 0.00 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 196 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 460 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 20 0.00 849: RADIOTHERAPY 23 … DIAGNOSIS W MCC 196 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 460 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 20 0.00 849: RADIOTHERAPY 23

  4. Neds 2016 Ip Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2016_IP_MaskedStats.PDF
    January 01, 2016 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 226 0.01 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 114 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 252 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 19 0.00 849: RADIOTHERAPY 30 … DIAGNOSIS W MCC 114 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 253 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 19 0.00 849: RADIOTHERAPY 30

  5. Neds 2007V2 Maskedstats Ip (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_IP.PDF
    April 09, 2010 - NEOPL W OTHER O.R.PROC 185 0.01 409: RADIOTHERAPY 26 0.00 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 13,159 0.42 464: SIGNS & SYMPTOMS W/O CC 4,268 0.14 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 12 0.00 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 187 0.01 467: OTHER … DIAGNOSIS W MCC <= 10 *.** 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 71 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 19 0.00 849: RADIOTHERAPY <

  6. Neds 2015Q4 Ip Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q4_IP_MaskedStats.PDF
    October 01, 2015 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 56 0.01 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 22 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 52 0.00 848 … : CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC <= 10 *.** 849: RADIOTHERAPY <= … DIAGNOSIS W MCC 22 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 52 0.00 848 … : CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC <= 10 *.** 849: RADIOTHERAPY <=

  7. Archived: Final Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
    June 15, 2008 - We did not consider secondary prevention studies that exclusively enrolled persons with known cardiovascular … All of the studies of angiotensin-converting enzyme inhibitors compared with placebo were secondary prevention … except for the HOPE (Heart Outcomes Prevention Evaluation) trial, which was a combination of primary and secondary … was a large, good-quality RCT examining the efficacy of an HMG-CoA reductase inhibitor in primary and secondary … β-Blockers: increase in withdrawals secondary to adverse events vs. placebo; NSD in total deaths.

  8. Szn5Hhs8W5Sar6Bbpabsab (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
    June 01, 2008 - We did not consider secondary prevention studies that exclusively en- rolled persons with known cardiovascular … All of the studies of angiotensin-converting en- zyme inhibitors compared with placebo were secondary … except for the HOPE (Heart Outcomes Prevention Evaluation) trial, which was a combination of primary and secondary … large, good- quality RCT examining the efficacy of an HMG-CoA re- ductase inhibitor in primary and secondary … �-Blockers: increase in withdrawals secondary to adverse events vs. placebo; NSD in total deaths.

  9. Cad-Women-Treatment Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
    August 01, 2012 - • Study did not report any of the primary or secondary outcomes of interest. … • Study did not report any of the primary or secondary outcomes of interest. 9 To aid in both … studies reported results for women for the primary composite outcome but not for each individual (secondary … Key Findings Our search identified 28 comparative studies (72 articles, including methodology and secondary … need for clinical researchers to provide study findings with women-specific data on the primary and secondary

  10. Disposition of Comments Report for Stroke Prevention in Atrial Fibrillation (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
    August 23, 2013 - Both the intention-to-treat results as well as the per-protocol results, a prespecified secondary analysis … We have now added these secondary efficacy outcomes from ROCKET and have clarified that these are from … Some ordered prioritization as to the most clinically meaningful or primary vs secondary could be helpful … example addressing the pre- specified primary outcomes of the new anticoagulant trials and the major secondary … We have now added these secondary efficacy outcomes from ROCKET and have clarified that these are from

  11. Learning from Errors in Ambulatory Pediatrics (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Mohr.pdf
    February 01, 2004 - studied child health topics as diverse as the prevalence of preschool vision screening,10 the onset of secondary … Secondary sexual characteristics and menses in young girls seen in office practice: a study from the

  12. Surveillance of Surgery-related Adverse Events in Missouri Using ICD-9-CM Codes (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Tuinen.pdf
    March 01, 2004 - Related Group (DRG) were included.18 Second, at least one of the flag codes had to be present in a secondary … associated with a specific AE class based on the first flag code encountered when searching through the 22 secondary

  13. CDS Artifact Enhancement Based on Pilot Implementation. Factors to Consider in Managing Chronic Pain: (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
    December 01, 2018 - element in the inclusion logic may be too broad since it includes medications used as primary and secondary … Evaluate Encounter diagnosis as a secondary way of capturing “Risk factors for opioid- related

  14. Final Progress Report: Prescription Opioid Use Trajectories and Risk Factors Associated with Opioid-Related Hospitalizations in Older Adults (pdf file)

    www.ahrq.gov/sites/default/files/2024-02/wei-report.pdf
    January 01, 2024 - Scope: The project used a secondary data approach to examine the associations of trajectories of prescription … To achieve the objective, the project team employed secondary data analyses of a 5% random sample of

  15. Supplemental Document No. 1 (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/measure_retirement/supplemental-materials/supplementaldoc1.pdf
    September 01, 2014 - To ensure that evidence reviews and other secondary information sources not available or not easily … To find primary literature or any additional secondary literature on the importance of each measure

  16. Final Progress Report: Patient Safety and the Primary Care Testing Process (pdf file)

    www.ahrq.gov/sites/default/files/2025-04/elder-report.pdf
    January 01, 2025 - • Secondary analysis of 600 error reports and transcripts from 18 focus groups from the AAFP DCERPS … • Secondary analysis of 600 error reports and transcripts from 18 focus groups from the American Academy

  17. Archived: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2003
    February 04, 2003 - 37  and ACE inhibitors and ARBs are useful antihypertensive agents for diabetics. 41 , 44 Several secondary … Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high‐density

  18. Changes in Hospitalizations and In-Hospital Deaths in the Initial Period of the COVID-19 Pandemic (April–December 2020), 29 States (pdf file)

    hcup-us.ahrq.gov/reports/statbriefs/sb290-COVID-19-AllHospital.pdf
    December 01, 2020 - Secondary diagnoses are conditions that coexist at the time of admission that require or affect patient … All-listed diagnoses include the principal diagnosis plus the secondary conditions.

  19. Most Frequent Reasons for Emergency Department Visits, 2018 (pdf file)

    hcup-us.ahrq.gov/reports/statbriefs/sb286-ED-Frequent-Conditions-2018.pdf
    January 01, 2018 - Secondary diagnoses are conditions that coexist at the time of the ED visit or inpatient admission, … All-listed diagnoses include the first-listed (principal) diagnosis plus the secondary conditions.

  20. Disposition of Comments_Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents: A Systematic Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disposition-comments.pdf
    April 10, 2025 - even teachers) are rarely used.It limited the usefulness to exclude studies of disruptive behavior "secondary … We excluded studies conducted in children with disruptive behavior secondary to ADHD because the ADHD
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (1196)

hcup-us.ahrq.gov (1163)

effectivehealthcare.ahrq.gov (808)

www.ahrq.gov (695)

digital.ahrq.gov (428)

www.uspreventiveservicestaskforce.org (380)

cds.ahrq.gov (21)

cdsic.ahrq.gov (16)

integrationacademy.ahrq.gov (8)

meps.ahrq.gov (7)

datatools.ahrq.gov (4)

qualityindicators.ahrq.gov (4)

pso.ahrq.gov (2)